- Home
- BBWI vs PCVX Comparison
BBWI vs PCVX Comparison
Compare BBWI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBWI
- PCVX
- Stock Information
- Founded
- BBWI 1963
- PCVX 2013
- Country
- BBWI United States
- PCVX United States
- Employees
- BBWI N/A
- PCVX N/A
- Industry
- BBWI Clothing/Shoe/Accessory Stores
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- BBWI Consumer Discretionary
- PCVX Health Care
- Exchange
- BBWI Nasdaq
- PCVX Nasdaq
- Market Cap
- BBWI 6.1B
- PCVX 4.3B
- IPO Year
- BBWI N/A
- PCVX 2020
- Fundamental
- Price
- BBWI $31.76
- PCVX $31.45
- Analyst Decision
- BBWI Buy
- PCVX Strong Buy
- Analyst Count
- BBWI 18
- PCVX 10
- Target Price
- BBWI $41.88
- PCVX $136.50
- AVG Volume (30 Days)
- BBWI 4.4M
- PCVX 2.3M
- Earning Date
- BBWI 06-03-2025
- PCVX 05-07-2025
- Dividend Yield
- BBWI 2.52%
- PCVX N/A
- EPS Growth
- BBWI N/A
- PCVX N/A
- EPS
- BBWI 3.61
- PCVX N/A
- Revenue
- BBWI $7,307,000,000.00
- PCVX N/A
- Revenue This Year
- BBWI $4.61
- PCVX N/A
- Revenue Next Year
- BBWI $3.01
- PCVX N/A
- P/E Ratio
- BBWI $8.80
- PCVX N/A
- Revenue Growth
- BBWI N/A
- PCVX N/A
- 52 Week Low
- BBWI $24.96
- PCVX $27.66
- 52 Week High
- BBWI $52.99
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- BBWI 57.09
- PCVX 37.17
- Support Level
- BBWI $29.74
- PCVX $28.09
- Resistance Level
- BBWI $31.37
- PCVX $36.71
- Average True Range (ATR)
- BBWI 1.10
- PCVX 2.47
- MACD
- BBWI 0.34
- PCVX 1.18
- Stochastic Oscillator
- BBWI 96.81
- PCVX 38.98
About BBWI Bath & Body Works Inc.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 5% of sales from international markets in fiscal 2024. For fiscal 2024, 76% of sales stemmed from the brick-and-mortar network (which was composed of more than 1,800 retail stores), similar to 2023 levels, as consumer shopping patterns remained to normal. Future growth is expected from store reformatting, digital and international channels, as well as adjacent category expansions like hair and laundry.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.